Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B

Steven W. Pipe

Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor

Wolfgang Miesbach

University Hospital Frankfurt, Frankfurt, Germany

Michael Recht

Yale School of Medicine, New Haven, CT

Frank W.G. Leebeek

Department of Hematology, Erasmus University Medical Center (UMC) Rotterdam, Rotterdam, the Netherlands

Nigel S. Key

Department of Medicine and Blood Research Center, University of North Carolina, Chapel Hill

Giancarlo Castaman

Center for Bleeding Disorders and Coagulation, Department of Heart, Lungs, and Vessels, Careggi University Hospital, Florence, Italy

Susan Lattimore

Oregon Heath and Science University, Portland

Michiel Coppens

Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam

Sandra Le Quellec

CSL Behring, King of Prussia, PA

Vaibhav Mahajan

CSL Behring, King of Prussia, PA

Sean Gill

CSL Behring, King of Prussia, PA

Douglass Drelich

CSL Behring, King of Prussia, PA

Paul E. Monahan

CSL Behring, King of Prussia, PA